Patent 9297250 was granted and assigned to Halliburton on March, 2016 by the United States Patent and Trademark Office.
In some aspects, an injection treatment of a subterranean region is controlled based on a target net treating pressure. A measure of fluid pressure acting on a subterranean region during an injection treatment is received. The measure of fluid pressure is compared against a target net treating pressure for fluid acting on the subterranean region during the injection treatment. The target net treating pressure is associated with a target fracture growth orientation. The injection treatment is modified based on a result of the comparison.